๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China ยท Delayed Price ยท Currency is CNY
12.13
-0.38 (-3.04%)
Nov 20, 2026, 3:04 PM CST

SHE:002275 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,0272,0462,1942,1721,9601,741
Revenue Growth
-2.60%-6.76%1.03%10.81%12.55%11.15%
Gross Profit
1,5251,5371,5841,5691,3851,284
Operating Income
502.64514.23485.33460.41315.65326.37
Net Income
422.25433.13521.53421.3329.53343.72
Earnings Per Share
0.720.740.890.720.560.60
EPS Growth
-19.99%-16.85%23.61%28.57%-6.67%25.00%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Industry
1,9642,1212,0981,869-
Commodity Circulation (Commercial)
49.941.2546.1948.8543.87
Other Business
31.3731.7527.4142.1518.38
Total
2,0462,1942,1721,9601,741

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,5761,7211,6761,4061,4271,699
Total Debt
356.14513.78593.63528.33465.88609.1
Net Cash (Debt)
1,2201,2081,082877.86961.071,090
Net Cash Growth
13.15%11.59%23.27%-8.66%-11.86%-18.50%
Net Cash Per Share
2.082.061.851.501.631.90

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
675.26708.12588.33549.25528.67410.24
Capital Expenditures
-94.62-86.94-82.18-76.4-62.27-144.09
Free Cash Flow
580.64621.18506.16472.85466.4266.15
Free Cash Flow Growth
0.19%22.72%7.04%1.38%75.24%-32.19%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
75.23%75.14%72.17%72.25%70.69%73.75%
Operating Margin
24.79%25.14%22.12%21.20%16.11%18.74%
Pretax Margin
25.55%26.25%29.35%23.87%22.77%24.64%
Profit Margin
20.83%21.17%23.77%19.40%16.81%19.74%
FCF Margin
28.64%30.36%23.07%21.77%23.80%15.29%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.5000.5000.6000.6000.8000.900
Dividend Per Share Growth
-18.18%-16.67%0%-25.00%-11.11%125.00%
Dividend Yield
4.12%3.55%3.98%4.14%6.21%5.32%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
16.8419.1317.0020.2122.9728.30
Forward PE
-17.0618.6315.3916.9216.92
P/FCF Ratio
12.2713.3417.5218.0116.2336.55
PS Ratio
3.524.054.043.923.865.59